Landscape Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Landscape Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.51M	Sell	20,146 -4,009	-17%	-$316K	0.1%	308
2025 Q4	$1.91M	Sell	24,155 -2,407	-9%	-$181K	0.13%	242
2025 Q3	$1.74M	Buy	+26,562	New	+$1.3M	0.11%	267
2025 Q1	–	Sell	-10,270	Closed	-$359K	–	749
2024 Q4	$359K	Sell	10,270 -15,165	-60%	-$567K	0.04%	476
2024 Q3	$1.02M	Buy	+25,435	New	+$1.18M	0.1%	260
2019 Q3	–	Sell	-13,605	Closed	-$874K	–	729
2019 Q2	$874K	Hold	13,605	–	–	0.07%	305
2019 Q1	$1.1M	Sell	13,605 -716	-5%	-$46.2K	0.1%	228
2018 Q4	$774K	Buy	+14,321	New	+$730K	0.06%	327
2018 Q3	–	Sell	-7,154	Closed	-$298K	–	744
2018 Q2	$298K	Buy	+7,154	New	+$317K	0.02%	391

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Landscape Capital Management's IONS Position: Q1 2026 in Review

Landscape Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 17% in Q1 2026, selling an estimated $316K and leaving 20,146 shares worth $1.51M. The position accounts for 0.1% of the portfolio, ranked #308.

Landscape Capital Management first reported a position in IONS in Q2 2018 and has held it in 9 quarters since. The position peaked at $1.91M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Landscape Capital Management held 20,146 shares of Ionis Pharmaceuticals worth $1.51M as of Q1 2026.
Landscape Capital Management sold 4,009 Ionis Pharmaceuticals shares in Q1 2026, an estimated $316K.
Ionis Pharmaceuticals made up 0.1% of Landscape Capital Management's portfolio in Q1 2026, its #308 holding.
Landscape Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2018 and has held it in 9 quarters since.
Landscape Capital Management's Ionis Pharmaceuticals position peaked at $1.91M in Q4 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.